UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000026527 |
|---|---|
| Receipt number | R000030459 |
| Scientific Title | Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment in patients with metastatic colorectal cancer(WJOG9216G) |
| Date of disclosure of the study information | 2017/03/24 |
| Last modified on | 2024/03/18 09:21:53 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/03/13 14:43:00 | ||
| 2 | Update | 2017/06/01 09:17:23 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2017/09/12 09:29:59 | Organization Organization Division name Address TEL |
|
| 4 | Update | 2017/09/13 10:23:43 | Division name Address |
|
| 5 | Update | 2022/03/01 13:26:08 | Recruitment status Date of IRB Last follow-up date |
|
| 6 | Update | 2022/11/07 10:08:14 | Recruitment status |
|
| 7 | Update | 2022/11/07 10:08:42 | Recruitment status |
|
| 8 | Update | 2024/03/18 09:21:53 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Name of person sending information Name of person sending information Organization1 Address1 Email1 Organization Organization Address Address Tel |
